These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32518053)

  • 61. Secukinumab for PASS syndrome: A new choice for therapeutic challenge?
    Li M; Xiang H; Liang Y; Xue L; Zhou X; Yang L; Liu H; Yang M; Tang J; Li W
    Dermatol Ther; 2022 Jul; 35(7):e15507. PubMed ID: 35419914
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Spectrum of diseases associated with pyoderma gangrenosum and correlation with effectiveness of therapy: New insights on the diagnosis and therapy of comorbid hidradenitis suppurativa.
    Fischer AH; Jourabchi N; Khalifian S; Lazarus GS
    Wound Repair Regen; 2022 May; 30(3):338-344. PubMed ID: 35385180
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Pyogenic arthritis, pyoderma gangrenosum and acne syndrome (PAPA syndrome)].
    Renn CN; Helmer A; Megahed M
    Hautarzt; 2007 May; 58(5):383-4. PubMed ID: 17447041
    [No Abstract]   [Full Text] [Related]  

  • 64. Severe ulcerative proctitis, pyoderma gangrenosum, hidradenitis suppurativa and fever in a patient with a rare variant of the PSTPIP1 gene.
    Hieta N; Nuutinen H; Roivas J; Salminen K; Kujari H; Talve L; Toivonen M; Haanpää MK
    Clin Exp Dermatol; 2021 Oct; 46(7):1387-1390. PubMed ID: 34273117
    [No Abstract]   [Full Text] [Related]  

  • 65. Treatment of pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) with weight-based anakinra dosing in a Hepatitis B carrier.
    Jennings L; Molloy O; Quinlan C; Kelly G; O'Kane M
    Int J Dermatol; 2017 Jun; 56(6):e128-e129. PubMed ID: 28239847
    [No Abstract]   [Full Text] [Related]  

  • 66. Tumor Necrosis Factor Antagonists in the Treatment of Pyoderma Gangrenosum, Acne, and Suppurative Hidradenitis (PASH) Syndrome.
    Saint-Georges V; Peternel S; Kaštelan M; Brajac I
    Acta Dermatovenerol Croat; 2018 Jun; 26(2):173-178. PubMed ID: 29989876
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Molecular analysis of inflammatory diseases.
    Almughrbi AH; Crovella S
    Exp Dermatol; 2022 Sep; 31 Suppl 1():9-16. PubMed ID: 35451529
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Successful use of adalimumab to treat pyoderma gangrenosum, acne and suppurative hidradenitis (PASH syndrome) following colectomy in ulcerative colitis.
    Murphy B; Morrison G; Podmore P
    Int J Colorectal Dis; 2015 Aug; 30(8):1139-40. PubMed ID: 25564349
    [No Abstract]   [Full Text] [Related]  

  • 69. Imaging findings of sterile pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome: differential diagnosis and review of the literature.
    Martinez-Rios C; Jariwala MP; Highmore K; Duffy KW; Spiegel L; Laxer RM; Stimec J
    Pediatr Radiol; 2019 Jan; 49(1):23-36. PubMed ID: 30225645
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome: differential diagnosis of septic arthritis by regular detection of exceedingly high synovial cell counts.
    Löffler W; Lohse P; Weihmayr T; Widenmayer W
    Infection; 2017 Aug; 45(4):395-402. PubMed ID: 28251506
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Facing Crohn's: A Rare Association.
    Gausman V; McNeill MB; Balzora S
    Gastroenterology; 2020 Mar; 158(4):829-830. PubMed ID: 31843586
    [No Abstract]   [Full Text] [Related]  

  • 72. [Severe acne in autoinflammatory diseases].
    Faleri S; Feichtner K; Ruzicka T
    Hautarzt; 2016 Nov; 67(11):897-901. PubMed ID: 27448064
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pyoderma gangrenosum, acne and ulcerative colitis in a patient with a novel mutation in the PSTPIP1 gene.
    Zeeli T; Padalon-Brauch G; Ellenbogen E; Gat A; Sarig O; Sprecher E
    Clin Exp Dermatol; 2015 Jun; 40(4):367-72. PubMed ID: 25683018
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation.
    Marzano AV; Borghi A; Meroni PL; Cugno M
    Br J Dermatol; 2016 Nov; 175(5):882-891. PubMed ID: 27106250
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Familial acne inversa with acne conglobata in three generations.
    Prasad PV; Kaviarasan PK; Joseph JM; Madhuri S; Viswanathan P
    Indian J Dermatol Venereol Leprol; 2008; 74(3):283-5. PubMed ID: 18583816
    [No Abstract]   [Full Text] [Related]  

  • 76. Haematological involvement associated with a mild autoinflammatory phenotype, in two patients carrying the E250K mutation of PSTPIP1.
    Belelli E; Passarelli C; Pardeo M; Holzinger D; De Benedetti F; Insalaco A
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):113-115. PubMed ID: 28628471
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model.
    Vossen ARJV; van der Zee HH; Prens EP
    Front Immunol; 2018; 9():2965. PubMed ID: 30619323
    [No Abstract]   [Full Text] [Related]  

  • 78. A sporadic case of pyogenic arthritis, pyoderma gangrenosum and acne syndrome without an identifiable mutation.
    Park BM; Yun SJ; Lee SC; Lee JB
    Clin Exp Dermatol; 2014 Jan; 39(1):73-5. PubMed ID: 23692517
    [No Abstract]   [Full Text] [Related]  

  • 79. Successful treatment of PASS syndrome with IVIG and anti-IL-1 treatment: A case report.
    Kırmızıer G; Kılınç EA; Yıldırım NO; Türsen Ü
    Int J Rheum Dis; 2024 Mar; 27(3):e15114. PubMed ID: 38465508
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hidradenitis Suppurativa as a Potential Subtype of Autoinflammatory Keratinization Disease.
    Nomura T
    Front Immunol; 2020; 11():847. PubMed ID: 32508815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.